239 related articles for article (PubMed ID: 26198696)
21. Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England.
Kasteridis P; Ride J; Gutacker N; Aylott L; Dare C; Doran T; Gilbody S; Goddard M; Gravelle H; Kendrick T; Mason A; Rice N; Siddiqi N; Williams R; Jacobs R
Psychiatr Serv; 2019 Aug; 70(8):650-656. PubMed ID: 31109263
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic prescribing in Black and White hospitalised patients.
Connolly A; Taylor D; Sparshatt A; Cornelius V
J Psychopharmacol; 2011 May; 25(5):704-9. PubMed ID: 21511740
[TBL] [Abstract][Full Text] [Related]
23. Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy.
Brunette MF; Cotes RO; de Nesnera A; McHugo G; Dzebisashvili N; Xie H; Bartels SJ
Psychiatr Serv; 2018 Sep; 69(9):1021-1028. PubMed ID: 29879874
[TBL] [Abstract][Full Text] [Related]
24. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.
Park SC; Lee MS; Kang SG; Lee SH
J Korean Med Sci; 2014 May; 29(5):719-28. PubMed ID: 24851031
[TBL] [Abstract][Full Text] [Related]
25. Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.
Kadra G; Stewart R; Shetty H; MacCabe JH; Chang CK; Taylor D; Hayes RD
Acta Psychiatr Scand; 2018 Aug; 138(2):123-132. PubMed ID: 29845597
[TBL] [Abstract][Full Text] [Related]
26. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
Sneider B; Pristed SG; Correll CU; Nielsen J
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
[TBL] [Abstract][Full Text] [Related]
27. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study.
Campos Mendes J; Azeredo-Lopes S; Cardoso G
Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867
[TBL] [Abstract][Full Text] [Related]
28. Predictors of high-dose antipsychotic prescription in psychiatric patients in Hong Kong.
Hung GB; Cheung HK
Hong Kong Med J; 2008 Feb; 14(1):35-9. PubMed ID: 18239241
[TBL] [Abstract][Full Text] [Related]
29. Incorporating clinician insight and care plans into an audit and feedback initiative for antipsychotic prescribing to Medicaid-enrolled youth in Philadelphia.
Candon M; Shen S; Rothbard A; Reed A; Everett M; Demp N; Weingartner M; Fadeyibi O
BMC Health Serv Res; 2024 May; 24(1):574. PubMed ID: 38702737
[TBL] [Abstract][Full Text] [Related]
30. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.
Lao KSJ; Tam AWY; Wong ICK; Besag FMC; Man KKC; Chui CSL; Chan EW
Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1387-1394. PubMed ID: 28665012
[TBL] [Abstract][Full Text] [Related]
31. Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register.
Iqbal E; Mallah R; Jackson RG; Ball M; Ibrahim ZM; Broadbent M; Dzahini O; Stewart R; Johnston C; Dobson RJ
PLoS One; 2015; 10(8):e0134208. PubMed ID: 26273830
[TBL] [Abstract][Full Text] [Related]
32. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community.
Gisev N; Bell JS; Chen TF
J Clin Psychopharmacol; 2014 Jun; 34(3):307-12. PubMed ID: 24717256
[TBL] [Abstract][Full Text] [Related]
34. The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients.
Lochmann van Bennekom MWH; Gijsman HJ; Groenewoud H; Verkes RJ
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):129-134. PubMed ID: 33666400
[TBL] [Abstract][Full Text] [Related]
35. Ethnicity and quality of antipsychotic prescribing among in-patients in south London.
Connolly A; Taylor D
Br J Psychiatry; 2008 Aug; 193(2):161-2. PubMed ID: 18670004
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
[TBL] [Abstract][Full Text] [Related]
38. 'Real time' monitoring of antipsychotic prescribing in patients with dementia: a study using the Clinical Record Interactive Search (CRIS) platform to enhance safer prescribing.
Colling C; Mueller C; Perera G; Funnell N; Sauer J; Harwood D; Stewart R; Bishara D
BMJ Open Qual; 2020 Mar; 9(1):. PubMed ID: 32229485
[TBL] [Abstract][Full Text] [Related]
39. New users of antipsychotic medication: A population-based cohort study of occupational outcome measures in relation to antipsychotic on-label and off-label prescribing practices.
Baandrup L; Kruse M
Eur Psychiatry; 2016 Jan; 31():66-71. PubMed ID: 26437772
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic polypharmacy in schizophrenia: benefits and risks.
Barnes TR; Paton C
CNS Drugs; 2011 May; 25(5):383-99. PubMed ID: 21476610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
